PortfoliosLab logoPortfoliosLab logo
ETON vs. NGD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ETON vs. NGD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eton Pharmaceuticals Inc (ETON) and New Gold Inc. (NGD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


ETON

1D
-1.62%
1M
2.50%
YTD
86.81%
6M
89.16%
1Y
117.71%
3Y*
102.22%
5Y*
36.00%
10Y*

NGD

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ETON vs. NGD - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ETON
Eton Pharmaceuticals Inc
86.81%26.95%204.11%55.32%-34.27%-47.23%12.92%17.65%-4.23%
NGD
New Gold Inc.
4.25%251.21%69.86%48.98%-34.67%-31.51%148.86%16.28%-9.89%

Correlation

The correlation between ETON and NGD is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.05

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Nov 13, 2018

0.08

The correlation between ETON and NGD shifts across timeframes, from -0.01 (1 year) to 0.10 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

ETON:

-$0.05

NGD:

$1.61

PS Ratio

ETON:

10.20

NGD:

3.30

Total Revenue (TTM)

ETON:

$86.93M

NGD:

$1.46B

Gross Profit (TTM)

ETON:

$47.61M

NGD:

$758.26M

EBITDA (TTM)

ETON:

$5.70M

NGD:

$1.19B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ETON vs. NGD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ETON
ETON Risk / Return Rank: 8787
Overall Rank
ETON Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
ETON Sortino Ratio Rank: 8888
Sortino Ratio Rank
ETON Omega Ratio Rank: 8787
Omega Ratio Rank
ETON Calmar Ratio Rank: 8585
Calmar Ratio Rank
ETON Martin Ratio Rank: 8282
Martin Ratio Rank

NGD

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ETON vs. NGD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eton Pharmaceuticals Inc (ETON) and New Gold Inc. (NGD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ETONNGDDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.36

Calmar ratioReturn relative to maximum drawdown

3.27

Martin ratioReturn relative to average drawdown

6.73

ETON vs. NGD - Sharpe Ratio Comparison


Loading charts...

Drawdowns

ETON vs. NGD - Drawdown Comparison


Loading charts...

Drawdown Indicators


ETONNGDDifference

Max Drawdown

Largest peak-to-trough decline

-79.94%

Max Drawdown (1Y)

Largest decline over 1 year

-36.17%

Max Drawdown (3Y)

Largest decline over 3 years

-45.65%

Max Drawdown (5Y)

Largest decline over 5 years

-70.42%

Current Drawdown

Current decline from peak

-9.74%

Average Drawdown

Average peak-to-trough decline

-37.58%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.56%

Volatility

ETON vs. NGD - Volatility Comparison


Loading charts...

Volatility by Period


ETONNGDDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.63%

Volatility (6M)

Calculated over the trailing 6-month period

40.49%

Volatility (1Y)

Calculated over the trailing 1-year period

54.85%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

63.41%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

63.87%

Dividends

ETON vs. NGD - Dividend Comparison

Neither ETON nor NGD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ETON vs. NGD - Financials Comparison

This section allows you to compare key financial metrics between Eton Pharmaceuticals Inc and New Gold Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M20222023202420252026
24.27M
496.10M
(ETON) Total Revenue
(NGD) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ETON and NGD have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for ETON and NGD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer